Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
DB Treatment Period (28 Weeks)	STARTED	Placebo	34
DB Treatment Period (28 Weeks)	STARTED	Crinecerfont	69
DB Treatment Period (28 Weeks)	Received at Least 1 Dose of Study Drug	Placebo	33
DB Treatment Period (28 Weeks)	Received at Least 1 Dose of Study Drug	Crinecerfont	69
DB Treatment Period (28 Weeks)	COMPLETED	Placebo	31
DB Treatment Period (28 Weeks)	COMPLETED	Crinecerfont	66
DB Treatment Period (28 Weeks)	NOT COMPLETED	Placebo	3
DB Treatment Period (28 Weeks)	NOT COMPLETED	Crinecerfont	3
OL Treatment Period (24 Weeks)	STARTED	Placebo	31
OL Treatment Period (24 Weeks)	STARTED	Crinecerfont	66
OL Treatment Period (24 Weeks)	Received at Least 1 Dose of Study Drug	Placebo	31
OL Treatment Period (24 Weeks)	Received at Least 1 Dose of Study Drug	Crinecerfont	66
OL Treatment Period (24 Weeks)	COMPLETED	Placebo	15
OL Treatment Period (24 Weeks)	COMPLETED	Crinecerfont	29
OL Treatment Period (24 Weeks)	NOT COMPLETED	Placebo	16
OL Treatment Period (24 Weeks)	NOT COMPLETED	Crinecerfont	37

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNone stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04806451/flow